Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Gboxin | C22H33ClN2O2 | 2101315-36-8 | Details |
| Ipatasertib dihydrochloride；RG-7440 dihydrochloride;GDC-0068 dihydrochloride | C24H33Cl2N5O2 | 1396257-94-5 | Details |
| Inavolisib；RG6114;GDC-0077 | C18H19F2N5O4 | 2060571-02-8 | Details |
| GDC-0339 | C20H22F3N7OS | 1428569-85-0 | Details |
| Ravoxertinib hydrochloride；GDC-0994 (hydrochloride) | C21H19Cl2FN6O2 | 2070009-58-2 | Details |
| Gemcitabine elaidate；CO-101;Gemcitabine (elaidate);CP-4126;Gemcitabine 5'-elaidate | C27H43F2N3O5 | 210829-30-4 | Details |
| GGsTop；Nahlsgen | C13H18NO7P | 926281-37-0 | Details |
| Gidazepam；Gidasepam;Hydazepam;Hidazepam | C17H15BrN4O2 | 129186-29-4 | Details |
| Gisadenafil；UK-369003 | C23H33N7O5S | 334826-98-1 | Details |
| GI 181771 | C34H31N5O6 | 305366-98-7 | Details |
| Glesatinib hydrochloride；MGCD265 hydrochloride | C31H28ClF2N5O3S2 | 1123838-51-6 | Details |
| Glesatinib；MGCD265 | C31H27F2N5O3S2 | 936694-12-1 | Details |
| Glibornuride | C18H26N2O4S | 26944-48-9 | Details |
| Glisoxepide | C20H27N5O5S | 25046-79-1 | Details |
| GLP-1R Antagonist 1 | C16H11ClF6N4O2 | 488097-06-9 | Details |
| GLPG0974 | C25H25ClN2O4S | 1391076-61-1 | Details |
| Glucagon (1-29), bovine, human, porcine；Porcine glucagon;Glucagon | C153H225N43O49S | 16941-32-5 | Details |
| Glucagon (1-29), bovine, human, porcine hydrochloride；Porcine glucagon hydrochloride;Glucagon hydrochloride | 28270-04-4 | Details |
| Iloperidone；HP 873 | C24H27FN2O4 | 133454-47-4 | Details |
| GLUFOSFAMIDE；Glucosylifosfamide mustard;D 19575 | C10H21Cl2N2O7P | 132682-98-5 | Details |
| Glufosinate ammonium | C5H18N3O4P | 77182-82-2 | Details |
| Glufosinate | C5H12NO4P | 51276-47-2 | Details |
| Gly-PEG3-amine | C12H27N3O4 | 2110448-97-8 | Details |
| Glycerol phenylbutyrate；HPN-100 | C33H38O6 | 611168-24-2 | Details |
| Glyceryl monocaprate；Monocaprin;2,3-Dihydroxypropyl decanoate;DECANOIN | C13H26O4 | 26402-22-2 | Details |
| GMBS | C12H12N2O6 | 80307-12-6 | Details |
| GN44028；N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine | C18H15N3O2 | 1421448-26-1 | Details |
| GNE-049 | C27H32F2N6O2 | 1936421-41-8 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| GNE-207 | C29H30N6O3 | 2158266-58-9 | Details |
| Doxepin hydrochloride；Doxepin HCl;Novoxapin;Toruan;Aponal | C19H22ClNO | 1229-29-4 | Details |
| GNE-272 | C22H25FN6O2 | 1936428-93-1 | Details |
| GNE-371 | C24H25N5O3 | 1926986-36-8 | Details |
| GNE-4997 | C25H27F2N5O3S | 1705602-02-3 | Details |
| GNE-618 | C21H15F3N4O3S | 1362151-42-5 | Details |
| GNE-6468 | C23H16ClN3O4 | 1677668-27-7 | Details |
| GNE-781 | C27H33F2N7O2 | 1936422-33-1 | Details |
| GNE-955 | C22H24N8O | 1527523-39-2 | Details |
| GNE-0723；GNE 0723 | C16H8ClF6N5OS | 1883518-31-7 | Details |
| GNE 5729 | C17H10Cl2F3N5O | 2026635-66-3 | Details |
| GNF179 | C22H23ClFN5O | 1261114-01-5 | Details |
| Drospirenone；Dihydrospirorenone;ZK 3059 | C24H30O3 | 67392-87-4 | Details |
| GNF351 | C24H25N7 | 1227634-69-6 | Details |
| GPNA hydrochloride | C11H14ClN3O5 | 67953-08-6 | Details |
| GPP78；CAY10618 | C27H29N5O | 1202580-59-3 | Details |
| GPR120 Agonist 3；GPR120-IN-1 | C19H23ClF3NO3 | 1599477-75-4 | Details |
| GR 113808 | C19H27N3O4S | 144625-51-4 | Details |
| GR 159897 | C23H27FN2O2S | 158848-32-9 | Details |
| GR148672X | C15H11F3N2O2S | 263890-70-6 | Details |
| Griseoluteic acid | C15H12N2O4 | 489-76-9 | Details |
| GS-6201；CVT-6883 | C21H21F3N6O2 | 752222-83-6 | Details |
| GS-626510 | C25H22N4O | 1637770-13-8 | Details |
| Pirenzepine dihydrochloride；Tabe;Pirenzepine HCl;LS519;Bisvanil | C19H22ClN5O2 | 29868-97-1 | Details |
| GS-9901 | C22H17ClFN9O | 1640247-87-5 | Details |
| GSK-269984A | C20H15Cl2FNNaO3 | 892664-04-9 | Details |
| GSK-626616 | C18H10Cl2N4OS | 1025821-33-3 | Details |
| GSK-7975A | C18H12F5N3O2 | 1253186-56-9 | Details |
| GSK1379725A | C23H23FN6O3 | 1802251-00-8 | Details |
| GSK1702934A | C22H25N3O2S | 924377-85-5 | Details |
| GSK180 | C10H7Cl2NO4 | 1799725-26-0 | Details |
| GSK2033 | C29H28F3NO5S2 | 1221277-90-2 | Details |
| Uprosertib hydrochloride；GSK2141795 (hydrochloride) | C18H17Cl3F2N4O2 | 1047635-80-2 | Details |
| GSK2194069 | C25H24N4O3 | 1332331-08-4 | Details |
| Naftifine hydrochloride；Exoderil;Naftifungin;Naftin;Naftifine HCl | C21H22ClN | 65473-14-5 | Details |
| GSK2256294A；GSK 2256294 | C21H24F3N7O | 1142090-23-0 | Details |
| Nemiralisib；GSK2269557 (free base) | C26H28N6O | 1254036-71-9 | Details |
| GSK256073 | C10H13ClN4O2 | 862892-90-8 | Details |
| GSK2795039 | C23H26N6O2S | 1415925-18-6 | Details |
| GSK2798745 | C25H28N6O3 | 1419609-94-1 | Details |
| GSK2837808A | C31H25F2N5O7S | 1445879-21-9 | Details |
| GSK2838232 | C48H73ClN2O6 | 1443460-91-0 | Details |
| GSK3145095 | C20H17F2N5O2 | 1622849-43-7 | Details |
| GSK3186899；DDD-853651 | C19H28F3N7O3S | 1972617-87-0 | Details |
| GSK3395879 | C20H15F4N3O5S | 2215852-91-6 | Details |
| Olsalazine disodium；Olsalazine Sodium;Dipentum | C14H11N2NaO6 | 6054-98-4 | Details |
| GSK376501A | C32H37NO6 | 1010412-80-2 | Details |
| GSK8573 | C20H21NO3 | 1693766-04-9 | Details |
| GSK864 | C30H31FN6O4 | 1816331-66-4 | Details |
| GSK8814 | C28H35F2N5O3 | 1997369-78-4 | Details |
| GSK962 | C14H18N2O | 2049872-86-6 | Details |
| GT 949 | C30H37N7O2 | 460330-27-2 | Details |
| Guacetisal | C16H14O5 | 55482-89-8 | Details |
| GW-1100 | C27H25FN4O4S | 306974-70-9 | Details |
| GW-406381 | C21H19N3O3S | 221148-46-5 | Details |
| Levamlodipine；S-amlodipine;(S)-Amlodipine | C20H25ClN2O5 | 103129-82-4 | Details |
| GW-803430；GW-3430 | C25H24ClN3O3S | 515141-51-2 | Details |
| GW-870086 | C31H39F2NO6 | 827319-43-7 | Details |
| GW7604 | C25H22O3 | 195611-82-6 | Details |
| GW7647 | C29H46N2O3S | 265129-71-3 | Details |
| GW843682X；GW843682 | C22H18F3N3O4S | 660868-91-7 | Details |
| RGH-5526；GYKI-11679 | C16H25N5O3 | 69579-13-1 | Details |
| GYKI 53655 hydrochloride；GYKI53655 hydrochloride | C19H21ClN4O3 | 143692-48-2 | Details |
| H-Lys-Trp-Lys-OH | C23H36N6O4 | 38579-27-0 | Details |
| H2DCFDA；DCFH-DA;2',7'-Dichlorodihydrofluorescein diacetate | C24H16Cl2O7 | 4091-99-0 | Details |
| H2N-PEG2-CH2COOH | C6H13NO4 | 134978-97-5 | Details |
| Nitazoxanide；NSC 697855 | C12H9N3O5S | 55981-09-4 | Details |
| Halofantrine hydrochloride；SKF-102886;WR-171669 | C26H30Cl2F3NO.ClH | 36167-63-2 | Details |
| Halopemide | C21H22ClFN4O2 | 59831-65-1 | Details |
| Haloxon | C14H14Cl3O6P | 321-55-1 | Details |
| (Rac)-HAMI 3379；HAMI 3379 | C34H45NO8 | 712313-35-4 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | ||||